Navigating the future of drug development at the C-Path Global Impact Conference

FHS
August 8, 2024
11:38 am

Critical Path Institute (C-Path), whose mission is to lead collaborations that accelerate drug development, advancing better treatments for people worldwide, is proud to announce its inaugural C-Path Global Impact Conference (CGIC), taking place from September 9-11, 2024, at the Washington Marriott at Metro Center.

LUCARG-39D by Legend Biotech for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 4, 2024

Study reveals dopamine’s role in stress-induced cardiovascular responses

Under stress, animals change their behavior, such as through “fight or flight” or “freezing” response. Simultaneously, physiological responses essential for stress adaptation are triggered in

December 16, 2024

Ethical microbiome research with Indigenous communities: A framework for collaboration and sovereignty

Research on the trillions of microorganisms that make up a person’s microbiome can lead to medical breakthroughs to treat diseases like inflammatory bowel syndrome and

October 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.